Whole blood transcriptomic profiles can differentiate vulnerability to chronic low back pain

Area of Science:

• Genomics
• Pain Medicine
• Molecular Biology

Background:

• The transition from acute to chronic pain is not well understood.
• Identifying molecular mechanisms is crucial for developing targeted therapies for chronic pain conditions.

Purpose of the Study:

• To characterize the whole blood transcriptome associated with chronic low back pain.
• To identify the transcriptome changes during the transition from acute to chronic low back pain.

Main Methods:

• Comparative transcriptome analysis of whole blood samples.
• Comparison groups included: acute low back pain (resolving within 6 weeks) vs. chronic low back pain (at 6 months); and chronic low back pain (at onset) vs. healthy controls.

Main Results:

• A distinct chronic low back pain transcriptome was identified, enriched for pain, extracellular matrix, and major histocompatibility complex (MHC) genes.
• The transition from acute to chronic pain showed upregulated antigen presentation pathway (MHC class I and II) genes and downregulated mitochondrial oxidative phosphorylation genes.

Conclusions:

• Chronic low back pain exhibits a unique genomic signature.
• Specific gene expression patterns during the acute-to-chronic transition may indicate a predisposition to pain chronification.